O[C@H]1C[C@@H](O[C@@H]1CO)N1C=C(C(=O)NC1=O)C(F)(F)F
including the chemo-resistant mouse pancreatic ductal carcinoma as well as the human prostate tumor model LNCaP
These data suggest that direct inhibition of the oncogenic CBFβ-SMMHC fusion protein may be an effective therapeutic approach for inv(16) AML
It can serve as a very useful reagent to enhance the safety of hPSC-based treatments and facilitate safe transplantation of larger cell numbers
Smiles: COC1=CC2=C(NC3=CC(Br)=C(O)C=C3)N=CN=C2C=C1OC
WHI-P154 - CAS# 211555-04-3 Catalog No.:M6563-2 O[C@H]1C[C@@H](O[C@@H]1CO)N1C=C(C(=O)NC1=O)C(F)(F)FWHI P154, CAS No. 211555 04 3, is a JAK3 inhibitor with IC50 = 1. 8 microM. WHI P154 displays no activity at JAK1 or JAK2. WHI P154 also Inhibits STAT1 activation, iNOS expression and NO production in macrophages in vitro . Also inhibits other common kinases including EGFR (IC50 = 4 nM), Src, Abl, VEGFR, MAPK and PI 3 K and induces apoptosis in human glioblastoma cell lines (IC50 = 158 microM). Product information CAS Number: 211555 04 3 Molecular